<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00148889</url>
  </required_header>
  <id_info>
    <org_study_id>CD-DBS-2005-JM</org_study_id>
    <nct_id>NCT00148889</nct_id>
  </id_info>
  <brief_title>Double-blind, Multicenter Study to Assess the Efficacy of Bilateral Pallidal Stimulation in Patients With Medically Refractory Primary Cervical Dystonia</brief_title>
  <official_title>Prospective,Randomised, Double-blind, Multicenter Study to Assess the Efficacy and Safety of Bilateral Globus Pallidus Internus - in Patients With Medically Refractory Primary Cervical Dystonia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>German Parkinson Study Group (GPS)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Competence Network on Parkinson's Disease</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>German Parkinson Study Group (GPS)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the efficacy and safety of bilateral pallidal
      stimulation in patients with medically refractory primary cervical dystonia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary cervical dystonia (CD) affects about 20-40/100.000 population. The disease is chronic
      and life-long. The therapy of choice are local intramuscular Botulinum Toxin injections given
      every three months. Oral medication such as anticholinergics or dopamine depleting drugs are
      usually of limited efficacy or their use is limited by intolerable side-effects. About 5-10%
      of CD patients develop neutralizing antibodies against Botulinum Toxin. Two previous
      controlled multicenter trials have shown the efficacy and safety of bilateral pallidal
      stimulation in patients with primary segmental and generalized dystonia (one study was
      performed by our group).

      Following surgery, patients will be randomized 1:1 to verum or placebo stimulation for a
      period of three months. Primary outcome measure is the TWSTRS (Toronto Western Spasmodic
      Torticollis Rating Scale) - a validated and widely accepted physician-based outcome measure
      for cervical dystonia. The independent TWSTRS raters are movement disorders specialists
      unaware of the stimulation status (verum/placebo) and they compare the TWSTRS-score at
      baseline and 3-months follow-up. Our hypothesis is that stimulated patients will have a
      significantly better improvement of dystonia as compared to those without stimulation
      (placebo group).

      After the 3-months period, all patients are unblinded and receive continuous effective
      stimulation by the implanted system. Regular follow-up visits are scheduled every 12 months
      for 5 years postoperatively to assess the long-term efficacy of pallidal stimulation.
      Side-effects are assessed in a standardized way and include the assessment of surgery-induced
      as well as stimulation-induced side-effects.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2005</start_date>
  <completion_date type="Actual">April 2008</completion_date>
  <primary_completion_date type="Actual">April 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Toronto Western Spasmodic Torticollis Scale (TWSTRS) at 3 months following surgery (comparison between placebo and control group)</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>side-effects, quality of life, depression, pain, long-term efficacy</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">63</enrollment>
  <condition>Cervical Dystonia</condition>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham-stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Active GPI-DBS</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Deep brain stimulation (DBS)</intervention_name>
    <description>Bilateral pallidal stimulation with an implanted DBS device</description>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary cervical dystonia

          -  Disease duration 3 years or longer

          -  Adult patient (18 years or older)

          -  TWSTRS severity score 15 or more

          -  Non-response to Botulinum Toxin

          -  Non-response to oral antidystonic medication

          -  Informed consent

        Exclusion Criteria:

          -  Dementia (Mattis Dementia Rating Scale below 120)

          -  Severe depression (Beck Depression Inventory &gt;25)

          -  Previous functional stereotactic surgery

          -  Hemidystonia or generalized dystonia

          -  Severe brain atrophy

          -  Contraindication against surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joerg Mueller, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Neurology, Medical University Innsbruck, Anichstr. 35, A-6020 Innsbruck, Austria</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University Innsbruck, Department of Neurology</name>
      <address>
        <city>Innsbruck</city>
        <state>Tyrol</state>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurosurgery, Medical University Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, Charité, Humboldt-University Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinic of Neurosurgery, Medical University Hannover</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, University Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, University Kiel</name>
      <address>
        <city>Kiel</city>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department for Stereotaxy and Functional Neurosurgery, University Cologne</name>
      <address>
        <city>Köln</city>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, University Regensburg</name>
      <address>
        <city>Regensburg</city>
        <zip>93053</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, University Rostock</name>
      <address>
        <city>Rostock</city>
        <zip>18147</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hertie-Institute for Clinical Brain Research</name>
      <address>
        <city>Tübingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.kompetenznetz-parkinson.de</url>
    <description>Homepage Competence Network on Parkinson`s disease sponsored by the German government</description>
  </link>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 7, 2005</study_first_submitted>
  <study_first_submitted_qc>September 7, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 8, 2005</study_first_posted>
  <last_update_submitted>February 15, 2018</last_update_submitted>
  <last_update_submitted_qc>February 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cervical dystonia</keyword>
  <keyword>torticollis</keyword>
  <keyword>deep brain stimulation</keyword>
  <keyword>pallidal stimulation</keyword>
  <keyword>globus pallidus internus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dystonia</mesh_term>
    <mesh_term>Dystonic Disorders</mesh_term>
    <mesh_term>Torticollis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

